The company's stock has dropped by 11.68% in the past month, falling short of the Medical sector's loss of 1.82% and the S&P 500's gain of 4.44%. For the full year, the Zacks Consensus Estimates project earnings of -$5.51 per share and a revenue of $89.43 million, demonstrating changes of -184.02% and -75.91%, respectively, from the preceding year. Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a pro ...